Subject: CIIX Announces Substantial Revenue Growth in 2019

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
CIIX Announces Substantial Revenue Growth in 2019
Hot Stock to WatchHot Stock to Watch

Company:, Inc. (OTCQB: CIIX)


Price: 0.3105

Change (%): - 0.0195 (5.91)

Volume: 2,817
CIIX Chart Inc. (CIIX) Announces Sales Up 175% in Fiscal Year 2019

Organic growth in every segment of business; industrial hemp and CBD liquor product sales major drivers of growth

SAN GABRIEL, California, Sept. 3, 2019 /PRNewswire/ —, Inc. (OTCQB: CIIX) (“CIIX” or “the Company”), a premier provider of financial news and education for the Chinese-speaking community, today provided an update on its financial results for the fiscal year ended May 31, 2019 and outlook for fiscal year 2020.

The Company reported a 175% year-over-year increase in revenue for FY 2019.

The Company reported overall revenue of $6.5 million, up from $2.4 millionin FY 2018, largely attributed to a $3.8 million increase in sales revenue from industrial hemp and CBD liquor products, including new products introduced in China by the Company’s subsidiary, CBD Biotech, Inc.

“We have seen significant growth in revenues this year, primarily attributable to the Company’s CBD consumer products line in Asia,” stated Mr. Warren Wang CEO of “While we have been strategically focusing on industrial hemp and CBD sales, we are pleased with the progress we have seen in our legacy businesses, financial news, education subscriptions, and investor relations, where we are re-focused on organic growth. We expect to see the full result of these efforts in FY 2020.”

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks